Nodality

About:

Nodality develops biologically-informed clinical treatments for patients with cancer and autoimmune diseases.

Top Investors: TPG, Kleiner Perkins, Maverick Ventures, Maverick Capital, TPG Growth

Description:

Nodality, Inc., a biotechnology company, discovers and develops personal diagnostics characterizing cell signaling pathways in defined cellular sub-populations of malignant and normal cells from individual patients. The company focuses on hematological malignancies and autoimmune disorders. Nodality, Inc. was incorporated in 2003 and is based in San Francisco, California with an additional office in Franklin, Tennessee.

Total Funding Amount:

$62M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

2003-01-01

Contact Email:

info(AT)nodality.com

Founders:

Garry Nolan, Gwendolyn Ong, Omar D. Perez

Number of Employees:

51-100

Last Funding Date:

2012-07-17

IPO Status:

Private

Industries: